Kim, D-W, Wu, Y-L, Paolini, J, Usari, T, Iyer, S, Reisman, A, Wilner, KD, Tursi, J, Boyer, M, Ganju, V, Hughes, B, Pavlakis, N, Solomon, B, Varma, S, Berghmans, T, Canon, J-L, Demedts, I, Janssens, A, Louis, R, Pieters, T, Schallier, D, Surmont, V, da Silva, CM, Ferreira, C-GM, Hirsh, V, Joy, A, Laberge, F, Morzycki, W, Wierzbicki, R, Han, B, Liu, X, Qin, S, Shi, Y, Wang, Y, Wu, G, Wu, Y-L, Zhou, C, Ahvonen, J, Barlesi, F, Cadranel, J, Dansin, E, Fayette, J, Morere, J-F, Moro-Sibilot, D, Pujol, J-L, Quoix, E, Zalcman, G, Frickhofen, N, Schneider, C-P, Wehler, T, Mok, T, So, P, Cuffe, S, Bearz, A, Boni, C, Cappuzzo, F, Cognetti, F, De Braud, F, De Pas, T, Galetta, D, Migliorino, M, Rocco, D, Scagliotti, G, Tagliaferri, P, Tiseo, M, Aoe, K, Hida, T, Kato, T, Kozuki, T, Nakagawa, K, Niho, S, Nishio, M, Nokihara, H, Satouchi, M, Seto, T, Takahashi, T, Ahn, J-S, Kim, D-W, Kim, S-W, Berchem, G, Rodriguez, OA, Biesma, B, Dingemans, A-M, Smit, E, Helland, A, Barata, F, Gorbunova, V, Manikhas, G, Orlov, S, Leong, S, Lim, H-L, Soo, R, Tan, E-H, Nosworthy, A, Codes Villena, M, Felip, E, Garrido Lopez, P, Isla Casado, D, Martinez Banaclocha, N, Ponce Aix, S, Reguart Aransay, N, Rodriguez Abreu, D, Trigo Perez, J, Gautschi, O, Pless, M, Zippelius, A, Chang, G-C, Tsai, Y-H, Shparyk, Y
, Blackhall, F, Steele, N, Armenio, V, Dragnev, K, Dugan, M, Gadgeel, S, Gerber, D, Graziano, S, Gurubhagavatula, S, Horn, L, Jalal, S, Lauer, R, Mehra, R, Mekhail, T, Mirshahidi, H, Pakkala, S, Polikoff, J, Raftopoulos, H, Saleh, M, Salgia, R, Waqar, S & Solomon, B 2014, '
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.',
The New England Journal of Medicine, vol. 371, no. 23, pp. 2167-2177.
https://doi.org/10.1056/NEJMoa1408440